FDA approves treatment for rare form of lymphoma

BY JON GARINN

Jon Garinn blog image
On July 3, the Food and Drug Administration (FDA) granted accelerated approval to Beleodaq (belinostat) for treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL).



Integrative services can be found in the community

BY JON GARINN

Jon Garinn blog image
We've had a handful of responses to our recent feature on integrative therapies, including opponents who insist that integrative oncology is "sham science" and proponents who want to make integrative techniques more widely available.



Does cancer equal love?

BY GUEST BLOGGER

Jennifer Nassar
CURE's editor-at-large Kathy LaTour and I met up cancer survivors Diana DeVoe and Debbie Fitzer in Dallas to see "The Fault in Our Stars," based on the book by John Green.




Calendar of Events

Find events, fundraisers, workshops and teleconferences in CURE's calendar of events.

Power Couple: Doctor and Patient Communication

BY DEBORAH TOLMACH SUGERMAN

A strong therapeutic alliance between cancer patients and oncologists has numerous benefits.

Liver Cancer

Gradual Gains in Liver Cancer

BY HEATHER L. VAN EPPS, PHD

Refined treatments and targeted drugs signal slow yet significant progress for liver cancer.

Survivorship

Post-Traumatic Stress Disorder after Cancer

BY LACEY MARLOW

Cancer’s traumatic impact can have lasting effects.

Fertility

The Adoption Option

BY CHARLOTTE HUFF

Building a family after cancer treatment can be a productive challenge.